Data Suggests Crescendo Test Tracks Rheumatoid Arthritis Patients' Response to Anti-TNF Therapies
November 09, 2011
Data Suggests Crescendo Test Tracks Rheumatoid Arthritis Patients' Response to Anti-TNF Therapies
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Crescendo Aims for 'Full Launch Velocity' for Vectra DA, Focus on Educating RA Patients in 2013
January 9, 2013 / Pharmacogenomics Reporter - New Studies Suggest Crescendo's Vectra DA Can Track Rheumatoid Arthritis in Variety of Settings
December 12, 2012 / Pharmacogenomics Reporter - Crescendo Presents Data Indicating Vectra DA RA Test May Help ID Patients in Remission
June 8, 2012 / ProteoMonitor - Big Names Join Clinical Proteomics Push in 2011, Offering Ray of Optimism Amidst Difficult Year
January 6, 2012 / ProteoMonitor - Myriad Moving Eight Protein-Based Tests to Market; Priorities Include AD, Kidney Damage, Colon Cancer
November 4, 2011 / ProteoMonitor